EUVIMEDEUVIMED entdecken
Crossref

Mild Cognitive Impairment – History, Diagnosis and Treatment

Sinoff Gary

Neurology - Research & Surgery · 2018

DOI: 10.33425/2641-4333.1002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurology - Research & Surgery, 2018. Verfasst von Sinoff Gary.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the last twenty years, mild cognitive impairment (MCI) has come to the forefront of research because of the conversion rate of 10-15% annually to dementia, usually Alzheimer type, and with 40% conversion within 3-4 years.The need exists to treat dementia, especially Alzheimer's type, early on which may delay the progression of conversion and providing financial savings on a societal macro-level but also individual micro-level.Accordingly the diagnosis of MCI as the pre-dementia state is of the utmost importance.However not all MCI cases will convert, so there exists the prerequisite of finding the predictors for detecting the converters.The direction of research varies from neuroimaging, biochemical markers in blood and/or CSF, or clinical neuropsychological markers.This article will provide the history of defining the concept of MCI and an approach to the diagnosis, treatment, both pharmacological and non-pharmacological.

Zitieren

APA

Gary, S. (2018). Mild Cognitive Impairment – History, Diagnosis and Treatment. Neurology - Research & Surgery. https://doi.org/10.33425/2641-4333.1002

Vancouver

Gary S. Mild Cognitive Impairment – History, Diagnosis and Treatment. Neurology - Research & Surgery. 2018. doi:10.33425/2641-4333.1002

BibTeX
@article{Gary2018,
  author = {Gary, Sinoff},
  title = {Mild Cognitive Impairment – History, Diagnosis and Treatment},
  journal = {Neurology - Research & Surgery},
  year = {2018},
  doi = {10.33425/2641-4333.1002}
}
Kostenlos starten →